心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 JCS指南：急性冠脉综合征的诊断和治疗

2019-03-29 日本循环学会 Circ J. 2019 Mar 29.

急性冠脉综合征

急性冠脉综合征（ACS）是以冠状动脉粥样硬化斑块破裂或侵袭，继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征，包括急性ST段抬高性心肌梗死、急性非ST段抬高性心肌梗死和不稳定型心绞痛（UA）。2018年日本急性冠脉综合征的诊断和治疗指南共包括12部分内容，涉及ACS的概念和流行病学，院前管理，初始诊断和治疗，疾病评估和管理，二级预防等。

中文标题：

2018 JCS指南：急性冠脉综合征的诊断和治疗

英文标题：

JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

发布机构：

日本循环学会

发布日期：

2019-03-29

简要介绍：

急性冠脉综合征（ACS）是以冠状动脉粥样硬化斑块破裂或侵袭，继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征，包括急性ST段抬高性心肌梗死、急性非ST段抬高性心肌梗死和不稳定型心绞痛（UA）。2018年日本急性冠脉综合征的诊断和治疗指南共包括12部分内容，涉及ACS的概念和流行病学，院前管理，初始诊断和治疗，疾病评估和管理，二级预防等。 

拓展指南：与急性冠脉综合征相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 JCS指南：急性冠脉综合征的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=f01cc1c001e290f8, title=2018 JCS指南：急性冠脉综合征的诊断和治疗, enTitle=JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome., guiderFrom=Circ J. 2019 Mar 29., authorId=null, author=, summary=急性冠脉综合征（ACS）是以冠状动脉粥样硬化斑块破裂或侵袭，继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征，包括急性ST段抬高性心肌梗死、急性非ST段抬高性心肌梗死和不稳定型心绞痛（UA）。2018年日本急性冠脉综合征的诊断和治疗指南共包括12部分内容，涉及ACS的概念和流行病学，院前管理，初始诊断和治疗，疾病评估和管理，二级预防等。 , cover=, journalId=null, articlesId=null, associationId=588, associationName=日本循环学会, associationIntro=日本循环学会，《Circulation Journal》为其官方期刊，上面文章均为免费的，有指南专栏，发布其学会制定的相关指南。, copyright=0, guiderPublishedTime=Fri Mar 29 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>急性冠脉综合征（ACS）是以冠状动脉粥样硬化斑块破裂或侵袭，继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征，包括急性ST段抬高性心肌梗死、急性非ST段抬高性心肌梗死和不稳定型心绞痛（UA）。2018年日本急性冠脉综合征的诊断和治疗指南共包括12部分内容，涉及ACS的概念和流行病学，院前管理，初始诊断和治疗，疾病评估和管理，二级预防等。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>急性冠脉综合征</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=a1be41c001e13236" title="2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗" target=_blank>2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c35121c00162226a" title="2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理" target=_blank>2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b99411c00161866d" title="2018 台湾非ST段抬高型急性冠脉综合征的管理指南" target=_blank>2018 台湾非ST段抬高型急性冠脉综合征的管理指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c0d9b1c00160ae19" title="血小板功能检测在急性冠脉综合征患者抗血小板治疗中的应用专家共识" target=_blank>血小板功能检测在急性冠脉综合征患者抗血小板治疗中的应用专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=73b2e1c00159894a" title="2018 台湾专家共识：急性冠脉综合征抗血小板治疗不良反应管理" target=_blank>2018 台湾专家共识：急性冠脉综合征抗血小板治疗不良反应管理</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E6%80%A5%E6%80%A7%E5%86%A0%E8%84%89%E7%BB%BC%E5%90%88%E5%BE%81" target=_blank>有关急性冠脉综合征更多指南</a></ul>, tagList=[TagDto(tagId=360, tagName=急性冠脉综合征)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8471, appHits=494, showAppHits=9, pcHits=5609, showPcHits=3678, likes=90, shares=13, comments=10, approvalStatus=1, publishedTime=Thu Apr 25 00:26:29 CST 2019, publishedTimeString=2019-03-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Apr 25 00:26:29 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:36:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 JCS指南：急性冠脉综合征的诊断和治疗)])
2018 JCS指南：急性冠脉综合征的诊断和治疗
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184753, encodeId=b3c61184e53c8, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=031d2545738, createdName=1252eeeam32暂无昵称, createdTime=Sun Jan 16 08:25:44 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062308, encodeId=e2d0106230836, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/19/d5ce32122fc3e0219d0dca8544737adf.jpg, createdBy=e0372042608, createdName=cardio, createdTime=Wed Oct 20 17:08:50 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920193, encodeId=321292019341, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1a5446368, createdName=ms3000001347078342, createdTime=Wed Jan 27 08:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890975, encodeId=34668909e581, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:21 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890974, encodeId=cd868909e42a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:15 CST 2020, time=2020-10-10, status=1, ipAttribution=)]
    2022-01-16 1252eeeam32暂无昵称

    学习，谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184753, encodeId=b3c61184e53c8, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=031d2545738, createdName=1252eeeam32暂无昵称, createdTime=Sun Jan 16 08:25:44 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062308, encodeId=e2d0106230836, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/19/d5ce32122fc3e0219d0dca8544737adf.jpg, createdBy=e0372042608, createdName=cardio, createdTime=Wed Oct 20 17:08:50 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920193, encodeId=321292019341, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1a5446368, createdName=ms3000001347078342, createdTime=Wed Jan 27 08:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890975, encodeId=34668909e581, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:21 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890974, encodeId=cd868909e42a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:15 CST 2020, time=2020-10-10, status=1, ipAttribution=)]
    2021-10-20 cardio

    学习，谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184753, encodeId=b3c61184e53c8, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=031d2545738, createdName=1252eeeam32暂无昵称, createdTime=Sun Jan 16 08:25:44 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062308, encodeId=e2d0106230836, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/19/d5ce32122fc3e0219d0dca8544737adf.jpg, createdBy=e0372042608, createdName=cardio, createdTime=Wed Oct 20 17:08:50 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920193, encodeId=321292019341, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1a5446368, createdName=ms3000001347078342, createdTime=Wed Jan 27 08:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890975, encodeId=34668909e581, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:21 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890974, encodeId=cd868909e42a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:15 CST 2020, time=2020-10-10, status=1, ipAttribution=)]
    2021-01-27 ms3000001347078342

    认真学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1184753, encodeId=b3c61184e53c8, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=031d2545738, createdName=1252eeeam32暂无昵称, createdTime=Sun Jan 16 08:25:44 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062308, encodeId=e2d0106230836, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/19/d5ce32122fc3e0219d0dca8544737adf.jpg, createdBy=e0372042608, createdName=cardio, createdTime=Wed Oct 20 17:08:50 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920193, encodeId=321292019341, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1a5446368, createdName=ms3000001347078342, createdTime=Wed Jan 27 08:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890975, encodeId=34668909e581, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:21 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890974, encodeId=cd868909e42a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:15 CST 2020, time=2020-10-10, status=1, ipAttribution=)]
    2020-10-10 ms5000001961239662

    认真学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184753, encodeId=b3c61184e53c8, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=031d2545738, createdName=1252eeeam32暂无昵称, createdTime=Sun Jan 16 08:25:44 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062308, encodeId=e2d0106230836, content=学习，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/19/d5ce32122fc3e0219d0dca8544737adf.jpg, createdBy=e0372042608, createdName=cardio, createdTime=Wed Oct 20 17:08:50 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920193, encodeId=321292019341, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c1a5446368, createdName=ms3000001347078342, createdTime=Wed Jan 27 08:04:25 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890975, encodeId=34668909e581, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:21 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890974, encodeId=cd868909e42a, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Sat Oct 10 09:57:15 CST 2020, time=2020-10-10, status=1, ipAttribution=)]
    2020-10-10 ms5000001961239662

    谢谢

    0

相关指南

2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗

亚洲心血管专家小组（统称） · 2019-03-01

2018 欧洲联合共识声明：房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2018-07-21

血小板功能检测在急性冠脉综合征患者抗血小板治疗中的应用专家共识

世界华人检验与病理医师协会 · 2018-06-12

2018 台湾专家共识：急性冠脉综合征抗血小板治疗不良反应管理

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2018-05-30

急性冠状动脉综合征患者检测心肌肌钙蛋白的专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2017-04-25

非ST段抬高型急性冠脉综合征诊断和治疗指南（2016）

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2017-05-30